Home/Recalls/FDA-D-0341-2026
FDA DrugsClass II

Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, ...

Published: March 4, 2026Recall ID: D-0341-2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Product Description & Identification

Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268-069-15.

Additional Source Details

FieldValue
CityPulaski
StateTN
Openfda › UniiM6Q1EO9TD0
Openfda › RouteORAL
Openfda › Rxcui849389
Openfda › Spl id38566e1f-b7b1-540f-e063-6394a90a2760
Openfda › Brand nameAMANTADINE HCL
Openfda › Spl set id461e6444-189e-62ed-6c61-1c36a04459c6
Openfda › Package ndc › 150268-069-11
Openfda › Package ndc › 250268-069-15
Openfda › Product ndc50268-069
Openfda › Generic nameAMANTADINE HYDROCHLORIDE
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameAMANTADINE HYDROCHLORIDE
Openfda › Manufacturer nameAvPAK
Openfda › Application numberANDA078720
Openfda › Original packager product ndc69452-142
Event id98449
Address 1615 N 1st St
Address 2N/A
Code infoLot # 49261, Exp: 04/30/27
Postal code38478-2403
Report date20260304
Product typeDrugs
Product quantityN/A
Reason for recallFailed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260213
Initial firm notificationLetter
Center classification date20260223

Overview

  • Recalling FirmAvKARE
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide in the USA.
Official Agency Alert